# US 2026/0182910 A1 · Integrated Injection System and Communication Device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0182910 A1
- Document ID: US20260182910A1
- Status: Published application
- Kind: A1
- Application number: 19/547,740
- Filed: 2026-02-24
- Published: 2026-07-02
- Earliest claimed: 2012-07-10
- Assignees: Becton Dickinson France
- Applicants: Becton Dickinson France S.A.S.
- Inventors: Christophe Bureau; Roderick Hausser; Hervé Monchoix
- Web page: https://patentgrep.com/patent/US20260182910A1

## CPC

- A61B 5/4833: {Assessment of subject's compliance to treatment}
- A61B 5/0002: {Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network (endoradiosondes A61B5/07)}
- A61B 5/02055: {Simultaneously evaluating both cardiovascular condition and temperature}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/4866: {Evaluating metabolism (using breath test A61B5/083)}
- A61B 5/4872: {Body fat}
- A61B 5/6848: {Needles}
- A61B 5/6898: {Portable consumer electronic devices, e.g. music players, telephones, tablet computers}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 5/7475: {User input or interface means, e.g. keyboard, pointing device, joystick}
- A61M 5/009: {Electronic or electro-mechanical add-on modules}
- A61M 5/158: Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61M 5/20: Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 takes precedence)
- A61M 37/0015: {by using microneedles}
- A61B 5/002: {Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence)}
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/0215: by means inserted into the body
- A61B 5/024: Measuring pulse rate or heart rate
- A61B 5/02438: {with portable devices, e.g. worn by the patient}
- A61B 2560/0214: of power generation or supply
- A61B 2560/0462: Apparatus with built-in sensors
- A61B 2562/08: Sensors provided with means for identification, e.g. barcodes or memory chips
- A61M 5/142: Pressure infusion, e.g. using pumps
- A61M 2005/1588: {having means for monitoring, controlling or visual inspection, e.g. for patency check or for avoiding extravasation}
- A61M 2005/1726: {the body parameters being measured at, or proximate to, the infusion site}
- A61M 2037/0023: {Drug applicators using microneedles}
- A61M 2037/0061: {Methods for using microneedles}
- A61M 2205/0294: Piezoelectric materials
- A61M 2205/3576: with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2230/00: Measuring parameters of the user
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An integrated system for injection including an injection device in electronic connection with a communication device is provided. The external communication device may be a handheld electronic device such as a Smartphone or a dedicated reader such as a reader capable of reading information contained on an RFID tag. The injection device includes a needle and a drug delivery portion enclosed within an external housing. Optionally, a plurality of sensors is affixed to the surface of the needle to collect data about the injection and physical characteristics of the patient. The data may be recorded on a data capture module. The electronic chip may be a readable and writable electronic chip such as a non-volatile memory chip. Alternatively, the electronic chip is a passive RFID tag. The injection device may further include a data transmitter for sending information obtained from the data capture module to the external communications device.

## Claims

### Claim 1

An integrated injection system, the system comprising an injection device comprising a drug delivery portion and a data transmitter, and a communication device that is external to the injection device,
wherein the injection device further comprises a data capture module including at least one sensor, the module being configured to sense information about at least one of a physical condition and a behavior of a patient during an injection event by the at least one sensor,
wherein the data transmitter is configured to be in an electronic communication with the communication device,
wherein the data transmitter is configured to transmit at least a portion of the sensed information to the communication device,
wherein the injection device further comprises an external housing enclosing the drug delivery portion and the data transmitter, and
wherein the drug delivery portion includes an internal reservoir containing a pharmaceutical agent to be delivered to the patient, wherein the internal reservoir is formed within a substrate layer of the drug delivery portion, wherein the internal reservoir includes a circular labyrinth formed on a surface of the substrate layer, wherein the drug delivery portion further includes a needle, and wherein the needle is in fluid communication with the internal reservoir and extendable through at least a portion of the external housing.

### Claim 2 (depends on 1)

The integrated injection system of claim 1, wherein the drug delivery portion further includes a piezoelectric pump that is in fluid communication with each of the internal reservoir and a cannula of the needle such that, when actuated, the piezoelectric pump draws the therapeutic agent from the internal reservoir and expels the fluid through the needle.

### Claim 3 (depends on 2)

The integrated injection system of claim 2, wherein the piezoelectric pump includes a plurality of piezoelectric pumps that is in fluid communication with each of the internal reservoir and the cannula of the needle such that, when actuated, the plurality of piezoelectric pumps draws the therapeutic agent from the internal reservoir and expels the fluid through the needle.

### Claim 4 (depends on 1)

The integrated injection system of claim 1, wherein the drug delivery portion further includes a stopper having a pierceable septum configured for filling the internal reservoir via a needle inserted into the internal reservoir through the stopper.

### Claim 5 (depends on 1)

The integrated injection system of claim 1, wherein the drug delivery portion includes a plurality of expulsion layers, wherein each expulsion layer of the plurality of expulsion layers includes an actuation material, a fluid reservoir with a double labyrinth, and an expulsion port, such that in response to actuation, the actuation material of each expulsion layer flows through its expulsion port to an independent defined path of the fluid reservoir, and wherein the actuation material from the plurality of expulsion layers advances simultaneously through each independent defined path of the fluid reservoir.

### Claim 6 (depends on 1)

The integrated injection system of claim 1, wherein the injection device is configured to send an electrical signal with a predefined waveform through the needle into the body of the patient, and wherein a receiver device is configured to identify and process the predefined waveform to determine if the waveform of the signal measured by the receiver device is substantially similar to a reference injection signal waveform associated with the pharmaceutical agent being successfully injected into the body of the patient to determine if the pharmaceutical agent was successfully injected into the body of the patient.

### Claim 7 (depends on 1)

The integrated injection system of claim 1, wherein the at least one sensor is located on a portion of the needle which is positioned inside the body of the patient during the injection event.

### Claim 8 (depends on 1)

The integrated injection system of claim 1, wherein the data transmitter is configured to transmit a signal to the communication device when the pharmaceutical agent has been fully expelled from the internal reservoir, and wherein the communication device is configured to provide an indication which alerts a user that the pharmaceutical agent has been expelled from the internal reservoir in response to the signal.

### Claim 9 (depends on 1)

The integrated injection system of claim 1, wherein the at least one sensor is configured to measure a physical characteristic of the patient, and wherein the physical characteristic is metabolism, body temperature, heart rate, blood pressure, or body fat composition.

### Claim 10 (depends on 1)

The integrated injection system of claim 1, wherein the communication device is configured to analyze at least a portion of the sensed information to determine adherence to a prescribed treatment routine.

### Claim 11 (depends on 1)

The integrated injection system of claim 1, wherein the communication device is configured to analyze the sensed information in correlation with data obtained from other sources to determine adherence to a prescribed treatment routine.

### Claim 12 (depends on 1)

The integrated injection system of claim 1, wherein at least one of the injection device and the communication device is configured to store the sensed information from a plurality of different injection events.

### Claim 13 (depends on 1)

The integrated injection system of claim 1, wherein the data transmitter comprises a wireless transmitter, such that the electronic communication with the communication device is performed wirelessly.

### Claim 14 (depends on 1)

The integrated injection system of claim 1, wherein the communication device is configured to transmit at least a portion of the sensed information to at least one external system, wherein the communication device comprises a user interface display configured to provide at least a portion of the sensed information to a user, and wherein the communication device is a smart phone.

### Claim 15

An integrated injection device, the device comprising an injection device comprising a drug delivery portion and a data transmitter, and a communication device that is external to the injection device,
wherein the injection device further comprises a data capture module including at least one sensor, the module being configured to sense information about at least one of a physical condition and a behavior of a patient during an injection event by the at least one sensor,
wherein the data transmitter is configured to be in an electronic communication with the communication device,
wherein the data transmitter is configured to transmit at least a portion of the sensed information to the communication device,
wherein the injection device further comprises an external housing enclosing the drug delivery portion and the data transmitter, and
wherein the drug delivery portion includes an internal reservoir containing a pharmaceutical agent to be delivered to the patient, wherein the internal reservoir is formed within a substrate layer of the drug delivery portion, and wherein the internal reservoir includes a circular labyrinth formed on a surface of the substrate layer, wherein the drug delivery portion further includes a needle, and wherein the needle is in fluid communication with the internal reservoir and extendable through at least a portion of the external housing.

### Claim 16 (depends on 15)

The integrated injection device of claim 15, wherein the drug delivery portion further includes a piezoelectric pump that is in fluid communication with each of the internal reservoir and a cannula of the needle such that, when actuated, the piezoelectric pump draws the therapeutic agent from the internal reservoir and expels the fluid through the needle.

### Claim 17 (depends on 16)

The integrated injection device of claim 16, wherein the piezoelectric pump includes a plurality of piezoelectric pumps that is in fluid communication with each of the internal reservoir and the cannula of the needle such that, when actuated, the plurality of piezoelectric pumps draws the therapeutic agent from the internal reservoir and expels the fluid through the needle.

### Claim 18 (depends on 15)

The integrated injection device of claim 15, wherein the drug delivery portion further includes a stopper having a pierceable septum configured for filling the internal reservoir via a needle inserted into the internal reservoir through the stopper.

### Claim 19 (depends on 15)

The integrated injection device of claim 15, wherein the drug delivery portion includes a plurality of expulsion layers, wherein each expulsion layer of the plurality of expulsion layers includes an actuation material, a fluid reservoir with a double labyrinth, and an expulsion port, such that in response to actuation, the actuation material of each expulsion layer flows through its expulsion port to an independent defined path of the fluid reservoir, and wherein the actuation material from the plurality of expulsion layers advances simultaneously through each independent defined path of the fluid reservoir.

### Claim 20 (depends on 15)

The integrated injection device of claim 15, wherein the injection device is configured to send an electrical signal with a predefined waveform through the needle into the body of the patient, and wherein a receiver device is configured to identify and process the predefined waveform to determine if the waveform of the signal measured by the receiver device is substantially similar to a reference injection signal waveform associated with the pharmaceutical agent being successfully injected into the body of the patient to determine if the pharmaceutical agent was successfully injected into the body of the patient.
